Shanxi Liye Pharmaceutical Co, founded in June 2017 in Taiyuan with a registered capital of 45 million yuan ($7.07 million), is a general pharmaceutical company which mainly produces Chinese patent medicine preparation and western medicine preparation, supplemented by chemical synthesis active pharmaceutical ingredients (API). 

The company has 39 approved drugs including tablets, granules, soft capsules, eye drops, solutions, and API. Its cinametic acid tablets for cholecystitis, phacolysin eye drops for cataract and clofazimine soft capsules for multidrug-resistant tuberculosis are exclusive in China.

The company has an annual production capacity of 3 billion tablets, 600 million soft capsules, 20 million sterile eye drops, 20 million nasal drops, and 10 million bags of granules, with an estimated annual output value of 300 million yuan. 

Address: No 21 Huagong Road, Jinyuan district, Taiyuan city, Shanxi province

Tel: 0351-2526948